UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Jul 7, 2026
Sale
Calculated transaction value
$564.99K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Jul 6, 2026
Public filing date
Jul 7, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$547.25
Jul 6, 2026
Close before public filing
$547.25
Jul 6, 2026
Return since public filing
-6.24%
Through Aug 21, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,031 shares @ $548
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000092
Filing cohort
Transactions in this filing
Showing 10 of 10
Trades
10
Issuers
1
Estimated value
$6.5M
Buys / sales
0 / 8
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Jul 6, 2026 | $1.29M |
| United Therapeutics Corp UTHR | Sale | Jul 6, 2026 | $1.15M |
| United Therapeutics Corp UTHR Current | Sale | Jul 6, 2026 | $564.99K |
| United Therapeutics Corp UTHR | Sale | Jul 6, 2026 | $1.84M |
| United Therapeutics Corp UTHR | Sale | Jul 6, 2026 | $1.16M |
| United Therapeutics Corp UTHR | Sale | Jul 6, 2026 | $181.21K |
| United Therapeutics Corp UTHR | Sale | Jul 6, 2026 | $72.3K |
| United Therapeutics Corp UTHR | Sale | Jul 6, 2026 | $74.71K |
| United Therapeutics Corp UTHR | Sale | Jul 6, 2026 | $169.49K |
| United Therapeutics Corp UTHR | Exercise | Jul 6, 2026 | $0 |